The Mii Lab is where we take ideas to proof of concept. Where opportunities become products.
Headquartered in Rehovot, in the heart of Israel’s bio-research Mecca and adjacent to the famous Weizmann Institute, MII labs brings scientists and clinicians, entrepreneurs and big pharma together in a unique excellence center conducive to great breakthroughs in dermatology with a clear path to market.
Mission:
To take dermatology and skin care innovations from inception to clinical proof of concept in the shortest, most effective and lean way while positioning it for the next steps of high-quality pharmaceutical development.
The lab brings invaluable expertise and experience working with a range of active ingredients including poorly soluble compounds, new chemical entities (NCEs), small and large molecules, pro-drugs, and high potency compounds.
From concept to creation
With a focus on topical drug development, we have created a closed garden of innovation with built-in synergies – from concept to clinical proof,
for dermatological and skin-care technologies.
Wii are Mii
Among our team members we have more than 120 patents registered, a large variety of pre-clinical and clinical studies conducted across all phases, dozens of pharmaceutical and cosmetic products brought to market, and companies formed and exited with huge value created.
Inbal Ziv
CEO
Limor Regev Yuzik
CFO
Dr. Oron Yacoby-Zeevi
CTO
Prof. Yuval Ramot
Chief Medical Officer
Yonit Tsarfati
Operations & Preclinical Manager
Dr. Luba Shapiro
Clinical Manager
Miri Refael
QA Manager
Ortal Shalom
Project Manager
Oded Aharon
Project Manager
Natalie Zarubinsky
Analytical Supervisor
Nir Rapaport
Formulation Scientist
Inna Zigelboim
Director of Administration